| Dr Todd Michael Reiter, | |
|
190 Kimel Park Dr Ste 131, Winston Salem, NC 27103-6946 | |
| (336) 718-5763 | |
| (336) 718-9861 |
| Full Name | Dr Todd Michael Reiter |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 20 Years |
| Location | 190 Kimel Park Dr Ste 131, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194917732 | NPI | - | NPPES |
| 5917822 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NR0400X | Chiropractor - Rehabilitation | 3777 (North Carolina) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 2009-01103 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Pain Solutions Pllc | 3678527181 | 19 |
News Archive
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.
Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.
A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 6 days ago
| Provider Name | High Point Regional Health |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396746228 PECOS PAC ID: 8426968371 Enrollment ID: O20031224000051 |
News Archive
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.
Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.
A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 6 days ago
| Provider Name | Integrated Pain Solutions Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1790728921 PECOS PAC ID: 3678527181 Enrollment ID: O20050308000817 |
News Archive
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.
Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.
A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 6 days ago
| Provider Name | Longevity And Performance Clinic Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124726377 PECOS PAC ID: 2062879026 Enrollment ID: O20230606002897 |
News Archive
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.
Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.
A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd Michael Reiter, Po Box 60447, Charlotte, NC 28260-0447 Ph: (336) 893-3210 | Dr Todd Michael Reiter, 190 Kimel Park Dr Ste 131, Winston Salem, NC 27103-6946 Ph: (336) 718-5763 |
News Archive
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.
Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.
Tart cherries may help reduce chronic inflammation, especially for the millions of Americans suffering from debilitating joint pain and arthritis, according to new research from Oregon Health & Science University presented today at the American College of Sports Medicine Conference (ACSM) in San Francisco, Calif.
A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition.
Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman's breast density and individual risk factors.
› Verified 6 days ago